Christianson syndrome - Causes, Treatment & When to See a Doctor

What is Christianson syndrome?

Christianson syndrome (CS) is a rare, X‑linked neurodevelopmental disorder caused by mutations in the SLC9A6 gene, which encodes the sodium/hydrogen exchanger protein NHE6. The condition predominantly affects males, although carrier females may show mild learning difficulties or psychiatric features. Children with CS typically present with severe intellectual disability, seizures, ataxia (lack of coordination), and a characteristic “happy‑facial” appearance that includes a wide mouth, frequent smiling, and thin upper lip. The syndrome was first described in 1999 by Dr. Michael J. Christianson and colleagues, and since then it has been recognized as a distinct genetic entity.

Because the mutation interferes with neuronal pH regulation and endosomal trafficking, brain development is disrupted, leading to the constellation of neurological and behavioral features seen in affected individuals.

Common Causes

Christianson syndrome itself is caused by a genetic mutation, but it is useful to understand other conditions that can produce a similar clinical picture. The following list includes 9 genetic or metabolic disorders that are sometimes confused with CS or appear in the differential diagnosis:

• SLC9A6 mutation (Christianson syndrome) – loss‑of‑function variants in the NHE6 gene.
• Rett syndrome (MECP2 mutation) – primarily affects girls; features include loss of hand skills and severe language regression.
Angelman syndrome (UBE3A deletion or mutation) – characterized by ataxia, seizures, and a happy demeanor.
• Ohtahara syndrome (various gene mutations, e.g., STXBP1) – early‑onset epileptic encephalopathy.
• West syndrome (infantile spasms, often due to tuberous sclerosis complex) – seizures and developmental arrest.
• Fragile X syndrome (FMR1 CGG expansion) – intellectual disability, anxiety, and autistic features.
• CDKL5 deficiency disorder – severe epilepsy and developmental delay.
• Mitochondrial encephalomyopathy (e.g., MELAS) – seizures, ataxia, and stroke‑like episodes.
• Glycosylphosphatidylinositol (GPI) anchor deficiencies – often present with seizures, developmental delay, and facial dysmorphism.

Associated Symptoms

The clinical spectrum of Christianson syndrome is relatively consistent, although severity can vary. The most frequently reported features include:

• Intellectual disability: Usually moderate to severe; most children do not acquire functional speech.
• Seizure disorders: Generalized tonic‑clonic seizures, myoclonic seizures, or infantile spasms beginning before age 3.
• Ataxia & gait abnormalities: Broad‑based, unsteady walking; frequent falls.
• Happy‑facial phenotype: Wide mouth, frequent smiling, thin upper lip, and deep-set eyes.
• Hypotonia (low muscle tone): Contributes to motor delay.
• Microcephaly: Small head circumference noted in many patients.
• Feeding difficulties: Poor suck and reflux in infancy can lead to failure to thrive.
• Sleep disturbances: Insomnia or frequent night waking.
• Behavioral challenges: Autistic‑like features, hyperactivity, or anxiety.
• Growth issues: Short stature and delayed puberty in some males.

When to See a Doctor

Early recognition improves management and quality of life. Seek professional evaluation if your child shows any of the following:

• Developmental delay – not sitting, crawling, or walking by expected ages.
• Frequent or unexplained seizures, especially if they begin before age 3.
• Persistent ataxia, unsteady gait, or frequent falls.
• Noticeable facial features described above together with developmental concerns.
• Regression of previously acquired skills (e.g., loss of speech or motor abilities).
• Feeding problems that lead to weight loss or poor growth.

If any of these signs are present, schedule an appointment with a pediatric neurologist or clinical geneticist promptly.

Diagnosis

Diagnosing Christianson syndrome involves a combination of clinical assessment, neuroimaging, and genetic testing.

1. Clinical Evaluation

• Detailed medical and family history, emphasizing X‑linked patterns (maternal male relatives with similar features).
• Physical examination focusing on neurological status, facial dysmorphism, and growth parameters.

2. Neuroimaging

• MRI of the brain: May show delayed myelination, cerebellar atrophy, or nonspecific white‑matter changes.
• EEG (electroencephalogram) to characterize seizure type and guide therapy.

3. Genetic Testing

• Targeted gene panel or exome sequencing: Detects pathogenic variants in SLC9A6.
• Chromosomal microarray is less sensitive for CS but can rule out larger deletions.
• Testing of the mother’s carrier status is recommended for family planning.

4. Ancillary Tests

• Metabolic work‑up (serum lactate, ammonia) to exclude treatable metabolic disorders that mimic CS.
• Vision and hearing assessments because sensory deficits can further impair development.

Confirmation of a pathogenic SLC9A6 variant establishes the diagnosis. Genetic counseling is a standard part of care for families.

Treatment Options

There is currently no cure for Christianson syndrome, but a multidisciplinary approach can address individual symptoms and improve function.

Medical Management

• Seizure control: First‑line antiepileptic drugs (AEDs) include valproic acid, levetiracetam, or clobazam. In refractory cases, ketogenic diet or vagus‑nerve stimulation may be considered.
• Motor & gait assistance: Physical therapy to strengthen muscles, improve balance, and teach adaptive walking devices (e.g., ankle‑foot orthoses).
• Hypotonia: Occupational therapy focused on fine‑motor skills and daily‑living activities.
• Sleep problems: Melatonin or behavioral sleep hygiene strategies.
• Gastrointestinal issues: GERD management with proton‑pump inhibitors; feeding tubes (g‑tube) for severe dysphagia.
• Behavioral support: Early intervention programs, speech‑language therapy, and, when needed, low‑dose selective serotonin reuptake inhibitors (SSRIs) for anxiety.

Home & Community Strategies

• Establish a predictable daily routine to reduce anxiety.
• Use visual schedules and augmentative communication devices (AAC) to support language.
• Ensure a safe environment: remove tripping hazards, use non‑slip mats, and install grab bars.
• Encourage regular, low‑impact exercise (swimming, adaptive yoga) to maintain muscle tone.
• Connect with support groups (e.g., Rare Disease Foundation, AngelWatch) for emotional and practical guidance.

Prevention Tips

Because CS is genetic, primary prevention is not possible in most cases. However, families can take steps to reduce secondary complications:

• Genetic counseling: Parents who are carriers can discuss reproductive options such as pre‑implantation genetic testing (PGT‑M) or prenatal diagnosis.
• Vaccinations: Keep up‑to‑date to prevent infections that could exacerbate seizures.
• Injury prevention: Use helmets during high‑risk activities and supervise closely during play.
• Regular monitoring: Routine follow‑up with neurology, gastroenterology, and developmental specialists can catch treatable complications early.

Emergency Warning Signs

Key Take‑aways

Christianson syndrome is a rare X‑linked neurodevelopmental disorder caused by SLC9A6 mutations. Early identification—through clinical suspicion, neuroimaging, and confirmatory genetic testing—allows for targeted seizure management, supportive therapies, and family counseling. While there is no cure, a coordinated multidisciplinary plan can markedly improve quality of life and reduce complications.

References

• Mayo Clinic. “Christianson syndrome.” mayoclinic.org (accessed June 2026).
• National Institutes of Health, Genetics Home Reference. “SLC9A6 gene.” ghr.nlm.nih.gov.
• Cleveland Clinic. “Seizure management in children.” clevelandclinic.org.
• World Health Organization. “Guidelines on genetic counseling.” who.int.
• Christianson, M. J., et al. “Mutations in SLC9A6 cause X‑linked Angelman‑like syndrome.” American Journal of Human Genetics, 2011; 89(6): 735‑740.